Previous study shows that researchers use recombinant AAV2 as a delivery vehicle to achieve long-lasting expression of VEGF-Trap protein in a mouse model, simultaneously suppressing primary tumor growth and preventing the metastases of tumors [46]. This evidence concerns the gene VEGFA and neoplasm.